Precision Toxicology™ & Efficacy

Hera News & Events

­

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

By |October 17th, 2017|

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

By |October 17th, 2017|

Using Cell Sheet Technique to Study the Development of HCC in Rat Models

As the single most prevalent primary liver cancer and the [...]

By |October 17th, 2017|

Understanding Circadian Rhythms in Humanized Mice

The human body’s circadian rhythm can significantly impact many biological [...]

By |October 17th, 2017|

Humanized Mice as Preclinical Models for Liver Stage Malaria Infection

Malaria continues to affect 250 million people around the world [...]

By |May 31st, 2017|

HIS Mice Provide New Preclinical Model for Human Skin Immunity

Despite the convenience and appeal of oral therapies, the reality [...]

By |May 31st, 2017|

What’s Old is New Again: Chemical Carcinogenesis Models of Cancer

Early cancer research focused primarily on chemical carcinogenesis in rat [...]

By |May 31st, 2017|

Hera Presents at SOT 2017 & AACR 2017 Recap

Hera strives to provide its clients with superior preclinical toxicology [...]

By |April 27th, 2017|

Chimeric Humanized Mouse Models: Understanding Human and Mouse Cell Interactions

Humanized liver mouse models are increasingly being used in preclinical [...]

By |February 28th, 2017|

Transposon Mutagenesis Helps Identify Genes Mediating Drug Resistance in the Treatment of CLL

First time treatment of Chronic Lymphocratic Leukemia (CLL) generally requires [...]

By |February 28th, 2017|